Opus Genetics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $2,882 | $4,370 | $4,302 | $3,867 |
Gross Profit | 4,370 | 4,292 | 3,867 | |
EBITDA | -8,906 | -6,809 | -35,125 | -7,526 |
EBIT | -6,822 | -35,135 | ||
Net Income | -7,420 | -8,194 | -35,135 | -7,526 |
Net Change In Cash | 2,882 | 4,370 | 4,302 | 3,867 |
Free Cash Flow | -10,269 | -8,994 | -7,438 | -5,130 |
Cash | 32,429 | 41,792 | 30,321 | 36,632 |
Basic Shares | 63,376 | 33,884 | 31,574 | 26,145 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $10,992 | $19,049 | $39,850 | $589 |
Gross Profit | 10,982 | 19,049 | 39,850 | 589 |
EBITDA | -57,522 | -9,968 | 18,216 | -56,687 |
EBIT | -57,532 | -9,974 | 18,212 | -56,691 |
Net Income | -57,532 | -9,986 | 17,888 | -56,693 |
Net Change In Cash | 10,992 | 19,049 | 39,850 | 589 |
Free Cash Flow | -25,576 | -1,112 | 14,314 | -19,370 |
Cash | 30,321 | 50,501 | 42,634 | 24,534 |
Basic Shares | 26,715 | 21,589 | 20,597 | 14,852 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$1.11 |
2024-09-30 | -$0.28 |
2024-06-30 | -$0.30 |
2024-03-31 | -$0.29 |
